NCT Number: NCT01228526
A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers
To evaluate the effectiveness of PriMatrix in the treatment of DFUs in subjects without significantly compromised arterial circulation.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
California School of Podiatric Medicine at Samuel Merritt University, Oakland, California, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Type I or Type II diabetes with investigator-confirmed reasonable metabolic control
- Peripheral neuropathy
- A full thickness diabetic plantar foot ulcer of at least 1 cm2 but not exceeding 10 cm2 in area
- An ulcer which has been in existence for a minimum of 30 days, prior to the day of screening
Exclusion criteria
- Suspected or confirmed signs/symptoms of wound infection
- Wounds with exposed bone or tendon
- Hypersensitivity to bovine collagen
Treatment and study plan
Primary outcomes
-
Percent of study ulcers healed
Time frame: Week 12
Sponsors and collaborators
Lead sponsor
Integra LifeSciences Corporation
Industry
Collaborators
- Circleville Foot & Ankle LLC
- Mayo Clinic
- New York College of Podiatric Medicine
- Samuel Merritt University
- Temple University
Registry information
Important dates
- Study start
- 2010
- Primary completion
- 2012
- Study completion
- 2012
- First posted
- Oct 26, 2010
- Registry last updated
- Aug 26, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Arterial Disease
NCT06952998
Foot Diseases, Foot Ulcer
Bilbao, Bizkaia, Spain
View Trial DetailsSALACIA: SALvesAn vs Conventional Management of dIAbetic Foot Wounds
NCT06908148
Foot Diseases, Foot Ulcer
View Trial DetailsPhase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)
NCT06319287
Cardiovascular Diseases, Diabetes Complications
Blue Ash, Ohio, United States
View Trial DetailsPersonalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention
NCT05236660
Cardiovascular Diseases, Diabetes Complications
Amsterdam, Netherlands
View Trial Details